Endothelin immunoreactivity and mRNA expression in sensory and sympathetic neurones following selective denervation.
The localization of endothelin (ET) in perivascular nerve varicosities supports pharmacological evidence that ET is a neurotransmitter in the autonomic nervous system. To examine the potential source of ET previously localized in cerebrovascular nerves, ganglia which send projections to these vessels were immunolabelled for ET and examined at the ultrastructural level. The trigeminal (TG) and superior cervical ganglia (SCG) were examined in control rats and following either sensory denervation or sympathectomy. In control TG, ET immunolabelling was detected throughout the cytoplasm of a subpopulation of neurones whereas in the SCG only the occasional ET-positive neurone was seen. Following sensory denervation with capsaicin, very few ET-immunoreactive nerve cell bodies or nerve fibres were detected in the TG compared with control ganglia, suggesting that ET is predominantly localized in primary afferent neurones, although some remaining myelinated nerve fibres stained positively. ET labelling of neurones in the SCG was unaffected by sensory denervation. Following selective damage to sympathetic nerves with 6-hydroxydopamine, there was a marked increase in intensity of ET-labelling of nerve fibres in the TG, probably due to increased availability of nerve growth factor for sensory nerves. There was no effect on ET immunoreactivity in the nerve cell bodies and nerve fibres within the SCG. However, in situ hybridization techniques demonstrated that 6-hydroxydopamine sympathectomy resulted in a marked increase in ET-1 mRNA expression in the SCG neurones. In conclusion, sensory nerves projecting from the TG are a more likely source of ET-positive perivascular nerves in cerebral arteries than sympathetic nerves from the SCG. Damaged sympathetic neurones markedly increase ET mRNA expression. In view of the neuroprotective properties of ET, this may represent a compensatory mechanism to promote repair.
Milner
P
P
Autonolic Neuroscience Institute, Royal Free and University College Medical School, London, UK. p.milner@ucl.ac.uk
Loesch
A
A
Burnstock
G
G
D000818:Animals; D000906:Antibodies; D019332:Endothelin-1 / Q000032:analysis* / Q000235:genetics* / Q000276:immunology; D015870:Gene Expression / Q000502:physiology; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D008854:Microscopy, Electron; D009412:Nerve Fibers / Q000737:chemistry / Q000648:ultrastructure; D009475:Neurons, Afferent / Q000737:chemistry* / Q000502:physiology / Q000648:ultrastructure; D016627:Oxidopamine; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D017783:Superior Cervical Ganglion / Q000737:chemistry / Q000166:cytology; D013563:Sympathectomy, Chemical; D013565:Sympatholytics; D012668:Trigeminal Ganglion / Q000737:chemistry / Q000166:cytology
D000906:Antibodies; D019332:Endothelin-1; D012333:RNA, Messenger; D013565:Sympatholytics; D016627:Oxidopamine